Bm Delta-pgm:一种具有跨种保护特性的羊种布鲁氏菌疫苗
布鲁氏菌病是重要的人兽共患病,羊种布鲁氏菌(Brucella melitensis)对人兽均有高侵袭性,现有疫苗Rev 1残余毒力高且需点眼接种。本研究构建了磷酸葡萄糖变位酶(pgm)基因缺失的高度减毒株Bm Delta-pgm,小鼠感染模型显示其诱导强记忆性细胞免疫、不产生针对O抗原的抗体,并对羊种、流产种和猪种布鲁氏菌均具交叉保护。
要点
- Bm Delta-pgm是对羊种布鲁氏菌高度减毒的pgm基因缺失株。
- 小鼠模型中该疫苗诱导强记忆性细胞免疫,但不产生抗O抗原抗体。
- 交叉保护实验显示其可保护小鼠抵抗流产种和猪种布鲁氏菌感染。
核心结论
- Bm Delta-pgm在小鼠感染模型中赋予针对羊种布鲁氏菌的良好保护水平,并交叉保护流产种和猪种布鲁氏菌,提示其有望作为覆盖最重要布鲁氏菌种的通用疫苗(原文用「raising the possibility」)。
研究设计与样本
- 研究描述了一种新型高度减毒疫苗株Bm Delta-pgm的构建,该株为磷酸葡萄糖变位酶(pgm)基因的干净缺失。
- 保护效果评价采用小鼠感染模型。
主要发现
- Bm Delta-pgm株为pgm基因的干净缺失,pgm编码催化葡萄糖-6-磷酸转化为葡萄糖-1-磷酸的蛋白,后者是多种多糖生物合成的前体,包括脂多糖的O抗原和环状β-葡聚糖。
- 接种Bm Delta-pgm诱导强记忆性细胞免疫应答,但不产生针对O抗原的抗体。
- 交叉保护实验显示Bm Delta-pgm可保护小鼠抵抗流产种布鲁氏菌和猪种布鲁氏菌感染。
临床怎么用
- 原文结论未据此给出临床或生产应用推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Brucellosis remains one of the most worldwide distributed zoonosis inflicting serious economical and human health problems in many areas of the world. The disease is caused by different species of the genus Brucella that have different tropisms towards different mammals being the most relevant for human health Brucella abortus, Brucella melitensis and Brucella suis that infect cows, goats/sheep, and swine respectively. For B. melitensis, considered the species with more zoonotic potential and highly aggressive for animals, only one vaccine is available to date in the market: Rev 1. This attenuated strain has the disadvantage that is has a very high residual virulence for animals and humans and, for this reason, it is applied by ocular instillation which is technically challenging in many productive settings. For this reason, the search for new vaccines for caprine and ovine brucellosis is an active topic of research. We describe here the construction of a novel highly attenuated vaccine strain (Bm Delta-pgm) that confers excellent levels of protection against B. melitensis in the mouse model of infection. This strain is a clean deletion of the phosphoglucomutase (pgm) gene that codes for a protein that catalyzes the conversion of glucose-6-P to glucose-1-P, which is used as a precursor for the biosynthesis of many polysaccharides, including the O-antigen of the lipopolysaccharide and cyclic beta glucans. Our results indicate that vaccination with Bm Delta-pgm induces a robust memory cellular immune response but no antibody production against the O-antigen. Cross protection experiments show that this new vaccine protects against B. abortus and B. suis raising the possibility that Bm Delta-pgm could be used as a universal vaccine for the most important Brucella species.
引用
- Czibener C, Rey Serantes DA, Romani AM, et al. Bm Delta-pgm, a vaccine for the control of Brucella melitensis with cross-species protective properties. Vaccine. 2023. PMID: 37149444. doi:10.1016/j.vaccine.2023.04.076
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。